Internal Medicine, Hematology & Oncology · Gettysburg, PA
NPI
1487679593
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
20 Expedition Trl, Suite 101
Gettysburg, PA, 17325
Phone (717) 334-4033
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
133,223 services
Medicare patients, 2024
523
Average age 75
Drug cost, 2024
$9.0M
1,923 prescriptions
Company payments, 2025
$7,478
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Satish A Shah was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 17,501 times for 13 patients. In total Satish A Shah billed 133,223 services in 127 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 17,501 | 13 | $2.32 | $41K |
| J0897 Injection, denosumab, 1 mg | Office | 7,365 | 49 | $20.49 | $151K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,300 | 32 | $15.51 | $67K |
| 85025 Blood Count | Office | 1,741 | 447 | $7.53 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,633 | 448 | $8.64 | $14K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,584 | 17 | $6.01 | $9,516 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,352 | 31 | $0.09 | $119 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,090 | 22 | $0.72 | $780 |
| 99214 Office E&M - Established | Office | 950 | 314 | $98.08 | $93K |
| 96372 Injection Administration | Office | 485 | 99 | $11.20 | $5,432 |
| 96365 Intravenous Infusion, Hydration | Office | 362 | 87 | $48.71 | $18K |
| 96367 Intravenous Infusion, Hydration | Office | 301 | 58 | $22.36 | $6,730 |
| 96413 Chemotherapy Administration | Office | 277 | 55 | $100.80 | $28K |
| 96366 Intravenous Infusion, Hydration | Office | 263 | 21 | $16.25 | $4,274 |
| 99213 Office E&M - Established | Office | 256 | 171 | $68.04 | $17K |
By year: 2022 $959K for 79,659 services; 2023 $2.3M for 135,787 services; 2024 $2.3M for 133,223 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,741 | 447 | $7.53 | $13K |
| 36415 Venipuncture Blood Collection | 1,633 | 448 | $8.64 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Satish A Shah prescribed most often to Medicare patients was Octagam (Immun Globg(Igg)/Malt/Iga Ov50), with 193 prescriptions and refills. In total Satish A Shah wrote 1,923 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 193 | 197 | 15 | $1.4M |
| Procrit Epoetin Alfa | 148 | 150 | 29 | $411K |
| Lupron Depot Leuprolide Acetate | 100 | 156 | 17 | $303K |
| Xgeva Denosumab | 90 | 90 | 13 | $281K |
| Ogivri Trastuzumab-Dkst | 72 | 72 | Under 11 | $281K |
| Prednisone Generic | 67 | 75 | 25 | $425 |
| Letrozole Generic | 60 | 128 | 14 | $1,093 |
| Anastrozole Generic | 55 | 105 | 11 | $965 |
| Prochlorperazine Maleate Generic | 48 | 48 | 35 | $544 |
| Ondansetron Hcl Generic | 47 | 47 | 34 | $415 |
| Jakafi Ruxolitinib Phosphate | 42 | 42 | Under 11 | $840K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 41 | 43 | Under 11 | $249K |
| Abraxane Paclitaxel Protein-Bound | 39 | 39 | Under 11 | $149K |
| Xtandi Enzalutamide | 38 | 38 | Under 11 | $504K |
| Mvasi Bevacizumab-Awwb | 38 | 38 | Under 11 | $192K |
Brand drugs: 1,229 claims; generic drugs: - claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Satish A Shah $7,478 ($7,478 in general payments such as food, travel and fees) from 23 companies. The largest payer was Genzyme Corporation with $5,791.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 3 | $5,791 |
| Fennec Pharmaceuticals, Inc. FENC | 3 | $335 |
| Caris MPI, Inc. | 5 | $289 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $177 |
| Celltrion USA Inc. 068270.KS | 1 | $150 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $125 |
| Daiichi Sankyo Inc. 4568.T | 1 | $99.99 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $99.13 |
| Amgen Inc. AMGN | 2 | $59.77 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $44.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.